*In December 2018, NICE updated its guidelines to recommend a LAMA/LABA as first-line maintenance therapy in patients with no asthmatic features/features suggesting steroid responsiveness who remain breathless/have exacerbations despite short acting bronchodilator therapy.
NICE also specifies that such patients should have spirometrically confirmed COPD, have been offered/received treatment for tobacco dependence (if smokers), had optimised non-pharmacological management and received relevant vaccinations.
Click on the image to view NICE's summary (see infographic below) of its COPD recommendations.
© NICE 2019 Chronic obstructive pulmonary disease in over 16s: non-pharmacological management and use of inhaled therapies. Available from www.nice.org.uk/guidance/NG115 All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.
For more information on the NICE COPD guidelines see www.nice.org.uk/guidance/NG115